![]() |
Volumn 14, Issue 6, 2007, Pages 686-689
|
Cladribine in aggressive forms of multiple sclerosis
|
Author keywords
Cladribine; Immunotherapy; Multiple sclerosis
|
Indexed keywords
BETA INTERFERON;
CLADRIBINE;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
GADOLINIUM;
GLATIRAMER;
IMMUNOGLOBULIN;
METHOTREXATE;
ABSENCE OF SIDE EFFECTS;
ADOLESCENT;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
DISABILITY;
DISEASE ACTIVITY;
DISEASE SEVERITY;
DRUG TREATMENT FAILURE;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
MULTIPLE CYCLE TREATMENT;
MULTIPLE SCLEROSIS;
NEUROIMAGING;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RATING SCALE;
RELAPSE;
RETROSPECTIVE STUDY;
TREATMENT DURATION;
TREATMENT RESPONSE;
ADOLESCENT;
ADULT;
CLADRIBINE;
DISABILITY EVALUATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
RETROSPECTIVE STUDIES;
|
EID: 34249781425
PISSN: 13515101
EISSN: 14681331
Source Type: Journal
DOI: 10.1111/j.1468-1331.2007.01735.x Document Type: Article |
Times cited : (13)
|
References (9)
|